Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer

Clinical trial NCT03944265 · COMPLETED

Trial details

NCT number: NCT03944265
Sponsor: Thomas Jefferson University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Activating ALK Gene Mutation Negative Activating EGFR Gene Mutation Negative Activating ROS1 Gene Mutation Negative Health Care Provider Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8

Start date: 2019-02-08
Primary completion: 2020-12-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.